Background: Raised concentrations of plasma homocysteine and C-reactive protein (CRP) are associated with vascular disease and have also been implicated as independent risk factors for cognitive impairment in population studies. Objectives: To investigate the association of plasma homocysteine and CRP with cognition in patients scheduled for coronary artery bypass graft (CABG) surgery. Cognition was assessed in 264 patients using a standard battery of neuropsychological tests. Patients were classified as having preexisting cognitive impairment (PreCI) by reference to a healthy control group or postoperative cognitive dysfunction (POCD) by reference to baseline test scores. Results: PreCI was present in 37.3% of patients, and POCD was present in 18.3, 12.1 and 13.6% of patients at 1 week, 3 months and 12 months postoperatively. On multivariate analysis neither homocysteine nor CRP were independently associated with cognition at any testing time but were strongly associated with age and left ventricular function. Conclusion: PreCI and POCD are present in a substantial proportion of patients undergoing CABG surgery but there is no independent association with either baseline homocysteine or CRP levels. It is possible that cognitive impairment may result from the vascular disease rather than a direct association with either homocysteine or CRP.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.